Tailored polysulfonated compounds like suramin derivatives act as potent extracellular HIV-1 Tat inhibitors by targeting its basic domain, suggesting potential therapeutic value.
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for Tat-targeted antivirals; human trials required before any clinical consideration.
Rusnati et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: